When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
At its R&D Day today, argenx (ARGX+0.5%) will present data on two new pipeline candidates: ARGX-117, a next-generation complement-targeting antibody against C2 and ARGX-118, an antibody targeting a protein called Galectin-10 that plays a key role in severe asthma, in-licensed from Belgian outfit VIB.
More news on: argenx SE, Halozyme Therapeutics, Inc., Healthcare stocks news,